Latest filing published 17 Oct 2019 for Acadia Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Eric Alejandro Miller: trading record in brief
Eric Alejandro Miller discloses dealings in Acadia Pharmaceuticals Inc to SEC (Form 4). We count 10 filings; the first trade dates from 9 September 2019 and the latest from 15 October 2019.
On the market, this insider has only sold: 3 sales, €1.2M in total. Other entries cover 7 option exercises.
The record was last updated on 17 October 2019 with an option exercise in Acadia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Alejandro Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 417 sharesCommon StockSEC:0001209191-19-053494:0
- 147 shares@ US$39.650.3% of flowCommon StockSEC:0001209191-19-053494:1
- 7,500 shares@ US$20.657.2% of flowCommon StockSEC:0001209191-19-049231:0
- 3,900 shares@ US$32.285.9% of flowCommon StockSEC:0001209191-19-049231:1
- 6,063 shares@ US$29.248.3% of flowCommon StockSEC:0001209191-19-049231:2
- 4,439 shares@ US$36.547.6% of flowCommon StockSEC:0001209191-19-049231:3
- 4,593 shares@ US$35.807.7% of flowCommon StockSEC:0001209191-19-049231:4
- 1,972 shares@ US$16.501.5% of flowCommon StockSEC:0001209191-19-049231:5
- 28,467 shares@ US$39.4952.6% of flowCommon StockSEC:0001209191-19-049231:6
- 4,645 shares@ US$41.189.0% of flowCommon StockSEC:0001209191-19-049231:7
10 of 10 declarations
